Malin Carlsson
Director/Board Member chez A Bioscience Incentive AB
Profil
Malin Carlsson is a Board Member at A Bioscience Incentive AB.
Previously, Dr. Carlsson served as Chairman at Atlas Therapeutics AB.
From 2021 to 2023, Dr. Carlsson was the Chief Operating Officer & Executive Vice President at Alligator Bioscience AB.
Dr. Carlsson holds a doctorate degree from the University of Lund.
Postes actifs de Malin Carlsson
Sociétés | Poste | Début |
---|---|---|
A Bioscience Incentive AB | Director/Board Member | 01/01/2020 |
Anciens postes connus de Malin Carlsson
Sociétés | Poste | Fin |
---|---|---|
ALLIGATOR BIOSCIENCE AB | Chief Executive Officer | 01/06/2021 |
Atlas Therapeutics AB
Atlas Therapeutics AB Pharmaceuticals: MajorHealth Technology Part of Alligator Bioscience AB, Atlas Therapeutics AB develops and manufactures antibody drugs. The private company is based in Stockholm, Sweden. Atlas Therapeutics was acquired by Alligator Bioscience AB on October 18, 2013. | Chairman | - |
Formation de Malin Carlsson
University of Lund | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
ALLIGATOR BIOSCIENCE AB | Health Technology |
Entreprise privées | 2 |
---|---|
Atlas Therapeutics AB
Atlas Therapeutics AB Pharmaceuticals: MajorHealth Technology Part of Alligator Bioscience AB, Atlas Therapeutics AB develops and manufactures antibody drugs. The private company is based in Stockholm, Sweden. Atlas Therapeutics was acquired by Alligator Bioscience AB on October 18, 2013. | Health Technology |
A Bioscience Incentive AB |